MYLES HOWARD: Open Payments
NPI 1831152941 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,316 in 68 payments from 20 companies in 2025. Trend: 2023 $1,327 · 2024 $1,498 · 2025 $1,316
Food & beverage: $1,316
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $166 |
| Ardelyx, Inc. | 5 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $115 |
| Phathom Pharmaceuticals, Inc. | 11 | $114 |
| Gilead Sciences, Inc. | 4 | $89 |
| PFIZER INC. | 5 | $88 |
| Novo Nordisk Inc | 4 | $88 |
| Corcept Therapeutics | 4 | $75 |
| SHIELD THERAPEUTICS INC | 4 | $73 |
| Exact Sciences Corporation | 3 | $62 |
Products named: TRELEGY ELLIPTA, IBSRELA, CAPLYTA, VOQUEZNA, Korlym, ACCRUFER, Ozempic, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
